vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $208.9M, roughly 1.5× iRhythm Holdings, Inc.). ALBANY INTERNATIONAL CORP runs the higher net margin — 4.3% vs 2.7%, a 1.7% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 12.0%). ALBANY INTERNATIONAL CORP produced more free cash flow last quarter ($51.4M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 1.2%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
AIN vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $208.9M |
| Net Profit | $13.9M | $5.6M |
| Gross Margin | 31.1% | 70.9% |
| Operating Margin | 9.3% | 1.1% |
| Net Margin | 4.3% | 2.7% |
| Revenue YoY | 12.0% | 27.1% |
| Net Profit YoY | -21.5% | 518.5% |
| EPS (diluted) | $0.56 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $208.9M | ||
| Q3 25 | $261.4M | $192.9M | ||
| Q2 25 | $311.4M | $186.7M | ||
| Q1 25 | $288.8M | $158.7M | ||
| Q4 24 | $286.9M | $164.3M | ||
| Q3 24 | $298.4M | $147.5M | ||
| Q2 24 | $332.0M | $148.0M | ||
| Q1 24 | $313.3M | $131.9M |
| Q4 25 | $13.9M | $5.6M | ||
| Q3 25 | $-97.8M | $-5.2M | ||
| Q2 25 | $9.2M | $-14.2M | ||
| Q1 25 | $17.4M | $-30.7M | ||
| Q4 24 | $17.7M | $-1.3M | ||
| Q3 24 | $18.0M | $-46.2M | ||
| Q2 24 | $24.6M | $-20.1M | ||
| Q1 24 | $27.3M | $-45.7M |
| Q4 25 | 31.1% | 70.9% | ||
| Q3 25 | -19.1% | 71.1% | ||
| Q2 25 | 31.3% | 71.2% | ||
| Q1 25 | 33.4% | 68.8% | ||
| Q4 24 | 31.5% | 70.0% | ||
| Q3 24 | 30.3% | 68.8% | ||
| Q2 24 | 33.9% | 69.9% | ||
| Q1 24 | 34.7% | 66.3% |
| Q4 25 | 9.3% | 1.1% | ||
| Q3 25 | -44.6% | -4.4% | ||
| Q2 25 | 7.2% | -10.0% | ||
| Q1 25 | 9.8% | -20.5% | ||
| Q4 24 | 8.5% | -2.5% | ||
| Q3 24 | 8.4% | -34.1% | ||
| Q2 24 | 12.9% | -15.5% | ||
| Q1 24 | 12.4% | -28.9% |
| Q4 25 | 4.3% | 2.7% | ||
| Q3 25 | -37.4% | -2.7% | ||
| Q2 25 | 2.9% | -7.6% | ||
| Q1 25 | 6.0% | -19.3% | ||
| Q4 24 | 6.2% | -0.8% | ||
| Q3 24 | 6.0% | -31.3% | ||
| Q2 24 | 7.4% | -13.6% | ||
| Q1 24 | 8.7% | -34.6% |
| Q4 25 | $0.56 | $0.18 | ||
| Q3 25 | $-3.37 | $-0.16 | ||
| Q2 25 | $0.31 | $-0.44 | ||
| Q1 25 | $0.56 | $-0.97 | ||
| Q4 24 | $0.57 | $-0.03 | ||
| Q3 24 | $0.57 | $-1.48 | ||
| Q2 24 | $0.79 | $-0.65 | ||
| Q1 24 | $0.87 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $583.8M |
| Total DebtLower is stronger | $455.7M | — |
| Stockholders' EquityBook value | $726.2M | $152.7M |
| Total Assets | $1.7B | $1.0B |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $583.8M | ||
| Q3 25 | $108.3M | $565.2M | ||
| Q2 25 | $106.7M | $545.5M | ||
| Q1 25 | $119.4M | $520.6M | ||
| Q4 24 | $115.3M | $535.6M | ||
| Q3 24 | $127.2M | $522.0M | ||
| Q2 24 | $116.4M | $561.5M | ||
| Q1 24 | $125.4M | $569.1M |
| Q4 25 | $455.7M | — | ||
| Q3 25 | $480.6M | — | ||
| Q2 25 | $444.7M | — | ||
| Q1 25 | $416.4M | — | ||
| Q4 24 | $318.5M | — | ||
| Q3 24 | $362.2M | — | ||
| Q2 24 | $377.1M | — | ||
| Q1 24 | $439.1M | — |
| Q4 25 | $726.2M | $152.7M | ||
| Q3 25 | $739.3M | $121.9M | ||
| Q2 25 | $888.6M | $103.7M | ||
| Q1 25 | $900.0M | $86.7M | ||
| Q4 24 | $943.5M | $90.9M | ||
| Q3 24 | $991.0M | $71.8M | ||
| Q2 24 | $967.5M | $99.2M | ||
| Q1 24 | $967.5M | $90.3M |
| Q4 25 | $1.7B | $1.0B | ||
| Q3 25 | $1.7B | $995.2M | ||
| Q2 25 | $1.7B | $964.0M | ||
| Q1 25 | $1.7B | $926.1M | ||
| Q4 24 | $1.6B | $931.4M | ||
| Q3 24 | $1.8B | $909.7M | ||
| Q2 24 | $1.8B | $919.2M | ||
| Q1 24 | $1.8B | $909.8M |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.45× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $26.2M |
| Free Cash FlowOCF − Capex | $51.4M | $14.5M |
| FCF MarginFCF / Revenue | 16.0% | 6.9% |
| Capex IntensityCapex / Revenue | 6.9% | 5.6% |
| Cash ConversionOCF / Net Profit | 5.31× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $26.2M | ||
| Q3 25 | $43.9M | $34.9M | ||
| Q2 25 | $32.7M | $27.7M | ||
| Q1 25 | $2.1M | $-7.9M | ||
| Q4 24 | $78.5M | $19.2M | ||
| Q3 24 | $47.0M | $24.3M | ||
| Q2 24 | $83.4M | $11.8M | ||
| Q1 24 | $9.6M | $-52.0M |
| Q4 25 | $51.4M | $14.5M | ||
| Q3 25 | $25.9M | $20.1M | ||
| Q2 25 | $18.8M | $17.3M | ||
| Q1 25 | $-13.5M | $-17.3M | ||
| Q4 24 | $60.2M | $12.4M | ||
| Q3 24 | $31.6M | $15.5M | ||
| Q2 24 | $63.6M | $3.4M | ||
| Q1 24 | $-17.3M | $-61.8M |
| Q4 25 | 16.0% | 6.9% | ||
| Q3 25 | 9.9% | 10.4% | ||
| Q2 25 | 6.0% | 9.3% | ||
| Q1 25 | -4.7% | -10.9% | ||
| Q4 24 | 21.0% | 7.5% | ||
| Q3 24 | 10.6% | 10.5% | ||
| Q2 24 | 19.2% | 2.3% | ||
| Q1 24 | -5.5% | -46.8% |
| Q4 25 | 6.9% | 5.6% | ||
| Q3 25 | 6.9% | 7.7% | ||
| Q2 25 | 4.5% | 5.6% | ||
| Q1 25 | 5.4% | 5.9% | ||
| Q4 24 | 6.4% | 4.2% | ||
| Q3 24 | 5.2% | 6.0% | ||
| Q2 24 | 6.0% | 5.7% | ||
| Q1 24 | 8.6% | 7.4% |
| Q4 25 | 5.31× | 4.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 4.44× | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | 3.39× | — | ||
| Q1 24 | 0.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
